NCT06939400View on ClinicalTrials.gov

Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Glioblastoma Multiforme (GBM)
Interventions
PROCEDURE

Photodynamic therapy (PDT)

GBM patients recevied surgical combination photodynamic therapy

PROCEDURE

GBM patients recevied traditional treatment options

GBM patients recevied traditional treatment options (including surgery combined with radiotherapy and chemotherapy)

Trial Locations (1)

310014

Zhejiang Provincial People's Hospital, Hangzhou

All Listed Sponsors
collaborator

The Second Affiliated Hospital of Harbin Medical University

OTHER

lead

Zhejiang Provincial People's Hospital

OTHER